AstraZeneca reaffirms December 2011 financial guidance for 2011 and mid-term planning assumptions for the 2010 to 2014 period
During a routine consensus collection process, confidential Company information was inadvertently embedded in a spreadsheet template sent to the sell-side analyst community that follows the Company. This information is out of date planning information, and does not represent the Company’s view of expected financial performance for the full year 2011 or for future periods. The most recent update of the Company’s financial guidance for 2011 was issued on 20 December 2011. Today, the Company reaffirms this guidance; the Company continues to expect to report Core earnings per share for